Decoy Therapeutics Inc
(DCOY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 1,468 | 1,772 | 971 | 2,532 | 3,971 |
| Operating Income | -1,468 | -1,772 | -971 | -2,532 | -3,971 |
| Other Income | 43 | 56 | 89 | 89 | 94 |
| Pre-tax Income | -1,424 | -1,715 | -882 | -2,443 | -3,877 |
| Net Income Continuous | -1,424 | -1,715 | -882 | -2,443 | -3,877 |
| Net Income | $-1,424 | $-1,715 | $-882 | $-2,443 | $-3,877 |
| EPS Basic Total Ops | -35.53 | -49.03 | 56.37 | -78.11 | -171.66 |
| EPS Basic Continuous Ops | -35.57 | -49.05 | 56.70 | -78.05 | -171.66 |
| EPS Diluted Total Ops | -35.53 | -49.03 | 56.37 | -78.11 | -171.66 |
| EPS Diluted Continuous Ops | -35.57 | -49.05 | 56.70 | -78.05 | -171.66 |
| EPS Diluted Before Non-Recurring Items | -35.53 | -49.18 | -26.39 | N/A | N/A |
| EBITDA(a) | $-1,466 | $-1,771 | $-970 | $-2,527 | $-3,970 |